IMCO and CAYMAN
IMCO is pleased to announce its partnership with Cayman Chemicals, one of the leading companies that provides scientists worldwide with biochemical tools. The new joint venture will facilitate access to IMCO´s products in North America (U.S. and Canada) and worldwide.
Arne Holmgren, CEO of IMCO Corporation Ltd AB, commented, "we will share expertise and experience in tools for analysis of thioredoxin and glutaredoxin making this joint venture more competitive in the global market". Partnering with Cayman Chemicals is a strategic move to advance access to the global market".
A webcast of the announcement can be viewed at
IMCO Corporation Ltd AB is today a major vendor of products needed in research on thioredoxins, thioredoxin reductases and glutaredoxins.